These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6130293)

  • 1. Prognosis after immunosuppression of patients with crescentic nephritis requiring dialysis.
    Hind CR; Paraskevakou H; Lockwood CM; Evans DJ; Peters DK; Rees AJ
    Lancet; 1983 Feb; 1(8319):263-5. PubMed ID: 6130293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma exchange and immunosuppressive drugs in the treatment of glomerulonephritis due to antibodies to the glomerular basement membrane.
    Pusey CD; Lockwood CM; Peters DK
    Int J Artif Organs; 1983 Jul; 6 Suppl 1():15-8. PubMed ID: 6642729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma exchange and immunosuppressive drugs in the management of severe glomerulonephritis.
    Pusey CD; Lockwood CM
    Prog Clin Biol Res; 1982; 106():91-104. PubMed ID: 6757955
    [No Abstract]   [Full Text] [Related]  

  • 4. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
    Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
    Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmapheresis in treatment of acute oligoanuria in crescentic glomerulonephritis.
    Grcevska L; Polenaković M; Stojkovski L; Polenaković H
    Artif Organs; 1998 Oct; 22(10):827-30. PubMed ID: 9790079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and immunological evolution of oligoanuric anti-GBM nephritis treated by haemodialysis.
    Flores JC; Taube D; Savage CO; Cameron JS; Lockwood CM; Williams DG; Ogg CS
    Lancet; 1986 Jan; 1(8471):5-8. PubMed ID: 2867295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crescentic glomerulonephritis without immune deposits: clinicopathologic features.
    Stilmant MM; Bolton WK; Sturgill BC; Schmitt GW; Couser WG
    Kidney Int; 1979 Feb; 15(2):184-95. PubMed ID: 390211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-basement-membrane antibody mediated, rapidly progressive, glomerulonephritis. Diagnostic and therapeutic strategy based on a retrospective study of 14 cases].
    Bouget J; Le Pogamp P; Perrier G; Ramée MP; Rivalan J; Camus C; Thomas R; Chevet D
    Ann Med Interne (Paris); 1990; 141(5):409-15. PubMed ID: 2256583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of plasma exchange in severe idiopathic rapidly progressive glomerulonephritis. A report of ten cases.
    Burran WP; Avasthi P; Smith KJ; Simon TL
    Transfusion; 1986; 26(4):382-7. PubMed ID: 3727013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of circulating anti-glomerular basement membrane antibody three years after immunosuppressive treatment and plasma exchange.
    Hind CR; Bowman C; Winearls CG; Lockwood CM
    Clin Nephrol; 1984 Apr; 21(4):244-6. PubMed ID: 6733989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crescentic glomerulonephritis--which patients should be treated with plasma exchange?
    Bell GM; Cumming AD; Swainson CP; Winney RJ; Robson JS
    Life Support Syst; 1983; 1 Suppl 1():92-4. PubMed ID: 6336470
    [No Abstract]   [Full Text] [Related]  

  • 12. Glomerulonephritis associated with antibodies to neutrophil cytoplasm and glomerular basement membrane.
    McCance DR; Maxwell AP; Hill CM; Doherty CC
    Postgrad Med J; 1992 Mar; 68(797):186-8. PubMed ID: 1589376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapse in anti glomerular basement membrane antibody mediated crescentic glomerulonephritis.
    Wu MJ; Moorthy AV; Beirne GJ
    Clin Nephrol; 1980 Feb; 13(2):97-102. PubMed ID: 7363520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Simultaneous presence of antibodies against the glomerular basement membrane and anti-myeloperoxidase antibodies in 2 patients with rapidly progressive glomerulonephritis].
    Díaz Rodríguez C; Costero O; Torre A; De Alvaro F; Gil F; Picazo ML; Martínez-Ara J
    Nefrologia; 2002; 22(2):190-5. PubMed ID: 12085420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4.
    Savage CO; Pusey CD; Bowman C; Rees AJ; Lockwood CM
    Br Med J (Clin Res Ed); 1986 Feb; 292(6516):301-4. PubMed ID: 3080145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and prognosis in antibasement membrane antibody-mediated nephritis.
    Peters DK; Rees AJ; Lockwood CM; Pusey CD
    Transplant Proc; 1982 Sep; 14(3):513-21. PubMed ID: 7179435
    [No Abstract]   [Full Text] [Related]  

  • 17. Intensive plasma exchange in crescentic glomerulonephritis: help or no help?
    Glassock RJ
    Am J Kidney Dis; 1992 Sep; 20(3):270-5. PubMed ID: 1519608
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma exchange with a membrane filter in glomerulonephritis mediated by antibodies to glomerular basement membrane.
    Krediet RT; Balk AG; Egberts G; Arisz L
    Neth J Med; 1982; 25(8):255-61. PubMed ID: 7144992
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture's syndrome.
    Walker RG; Scheinkestel C; Becker GJ; Owen JE; Dowling JP; Kincaid-Smith P
    Q J Med; 1985 Jan; 54(213):75-89. PubMed ID: 3975346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Glomerular Basement Membrane Disease.
    McAdoo SP; Pusey CD
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1162-1172. PubMed ID: 28515156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.